ArticleSeminars in arthritis and rheumatism2025

Non-TNFi biologic and targeted synthetic DMARDs in rheumatoid arthritis-associated interstitial lung disease: A propensity score-matched, active-comparator, new-user study.

Halie Frideres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.